Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation

Design and validation of a histological scoring system for nonalcoholic fatty liver disease†

Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791 · see citing works

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781 · see citing works

Extracellular vesicles: Exosomes, microvesicles, and friends

Raposo, G., & Stoorvogel, W. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201211138 · Cited by 8,099 · see citing works

Macrophage activation and polarization: nomenclature and experimental guidelines

Murray, P. J., Allen, J. E., Biswas, S. K., Fisher, E. A., Gilroy, D. W., Goerdt, S., Gordon, S., Hamilton, J. A., Ivashkiv, L. B., Lawrence, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.008 · Cited by 6,337 · see citing works

Nonalcoholic Fatty Liver Disease

Rinella, M. E. (2015) · JAMA · doi:10.1001/jama.2015.5370 · Cited by 2,289 · see citing works

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): A multicentre, randomised, placebo-controlled trial

Neuschwander-Tetri, B. A., Loomba, R., Sanyal, A. J., Lavine, J. E., Van Natta, M. L., Abdelmalek, M. F., Chalasani, N., Dasarathy, S., Diehl, A. M., Hameed, B., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61933-4 · Cited by 2,237 · see citing works

Programmed Cell Death in Animal Development and Disease

Fuchs, Y., & Steller, H. (2011) · Cell · doi:10.1016/j.cell.2011.10.033 · Cited by 1,915 · see citing works

Liver Macrophages in Tissue Homeostasis and Disease

Krenkel, O., & Tacke, F. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.11 · Cited by 1,424 · see citing works

Extracellular Vesicles: Unique Intercellular Delivery Vehicles

Maas, S. L. N., Breakefield, X. O., & Weaver, A. M. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.11.003 · Cited by 1,419 · see citing works

Liver inflammation and fibrosis

Koyama, Y., & Brenner, D. A. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88881 · Cited by 1,295 · see citing works

An emerging role for neutrophil extracellular traps in noninfectious disease

Jorch, S. K., & Kubes, P. (2017) · Nature Medicine · doi:10.1038/nm.4294 · Cited by 1,244 · see citing works

Immunology in the liver — from homeostasis to disease

Heymann, F., & Tacke, F. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.200 · Cited by 1,180 · see citing works

Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

Ratziu, V., Harrison, S. A., Francque, S., Bedossa, P., Lehert, P., Serfaty, L., Romero-Gomez, M., Boursier, J., Abdelmalek, M., Caldwell, S., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.038 · Cited by 1,035 · see citing works

Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase

Talukdar, S., Oh, D. Y., Bandyopadhyay, G. K., Li, D., Xu, J., McNelis, J., Lu, M. M., Li, P., Yan, Q., Zhu, Y., et al. (2012) · Nature Medicine · doi:10.1038/nm.2885 · Cited by 966 · see citing works

Extracellular Vesicles in Cancer: Exosomes, Microvesicles and the Emerging Role of Large Oncosomes

Minciacchi, V. R., Freeman, M., & Vizio, D. D. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.02.010 · Cited by 900 · see citing works

Bone marrow-derived monocytes give rise to self-renewing and fully differentiated Kupffer cells

Scott, C. L., Zheng, F., De Baetselier, P., Martens, L., Saeys, Y., De Prijck, S., Lippens, S., Abels, C., Schoonooghe, S., Raes, G., et al. (2016) · Nature Communications · doi:10.1038/ncomms10321 · Cited by 860 · see citing works

Alternative M2 Activation of Kupffer Cells by PPARδ Ameliorates Obesity-Induced Insulin Resistance

Odegaard, J. I., Ricardo-González, R. R., Eagle, A. R., Vats, D., Morel, C. R., Goforth, M. H., Subramanian, V., Mukundan, L., Ferrante, A. W., & Chawla, A. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.04.003 · Cited by 840 · see citing works

Large Artery Remodeling and Dynamics following Simulated Microgravity by Prolonged Head-Down Tilt Bed Rest in Humans

Palombo, C., Morizzo, C., Baluci, M., Lucini, D., Ricci, S., Biolo, G., Tortoli, P., & Kozàkovà, M. (2015) · BioMed Research International · doi:10.1155/2015/342565 · Cited by 752 · see citing works

Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice

Miura, K., Kodama, Y., Inokuchi, S., Schnabl, B., Aoyama, T., Ohnishi, H., Olefsky, J. M., Brenner, D. A., & Seki, E. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.03.052 · Cited by 741 · see citing works

Toll‐like receptor‐4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non‐alcoholic steatohepatitis

Rivera, C. A., Adegboyega, P., van Rooijen, N., Tagalicud, A., Allman, M., & Wallace, M. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.04.019 · Cited by 693 · see citing works

Emerging role of extracellular vesicles in inflammatory diseases

Buzás, E. I., György, B., Nagy, G., Falus, A., & Gay, S. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.19 · Cited by 673 · see citing works

A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis

Friedman, S. L., Ratziu, V., Harrison, S. A., Abdelmalek, M. F., Aithal, G. P., Caballeria, J., Francque, S., Farrell, G., Kowdley, K. V., Craxi, A., et al. (2018) · Hepatology · doi:10.1002/hep.29477 · Cited by 671 · see citing works

Sterile inflammation in the liver

Kubes, P., & Mehal, W. Z. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.09.008 · Cited by 666 · see citing works

Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives

Arab, J. P., Karpen, S. J., Dawson, P. A., Arrese, M., & Trauner, M. (2017) · Hepatology · doi:10.1002/hep.28709 · Cited by 634 · see citing works

Kupffer cells in the liver

Dixon, L. J., Barnes, M., Tang, H., Pritchard, M. T., & Nagy, L. E. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c120026 · Cited by 628 · see citing works

Complexity of Danger: The Diverse Nature of Damage-associated Molecular Patterns

Schaefer, L. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.r114.619304 · Cited by 618 · see citing works

Saturated fatty acids activate TLR-mediated proinflammatory signaling pathways

Huang, S., Rutkowsky, J. M., Snodgrass, R. G., Ono‐Moore, K. D., Schneider, D. A., Newman, J. W. I., Adams, S. H., & Hwang, D. H. (2012) · Journal of Lipid Research · doi:10.1194/jlr.d029546 · Cited by 591 · see citing works

Scavenger Receptors in Atherosclerosis: Beyond Lipid Uptake

Moore, K. J., & Freeman, M. W. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000229218.97976.43 · Cited by 562 · see citing works

The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial

Loomba, R., Lawitz, E., Mantry, P. S., Jayakumar, S., Caldwell, S. H., Arnold, H., Diehl, A. M., Djedjos, C. S., Han, L., Myers, R. P., et al. (2018) · Hepatology · doi:10.1002/hep.29514 · Cited by 549 · see citing works

Pathogenesis of Nonalcoholic Steatohepatitis

Machado, M. V., & Diehl, A. M. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.066 · Cited by 541 · see citing works

Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes

Hirsova, P., Ibrahim, S. H., Krishnan, A., Verma, V. K., Bronk, S. F., Werneburg, N. W., Charlton, M., Shah, V. H., Malhi, H., & Gores, G. J. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.12.037 · Cited by 510 · see citing works

Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2

Miura, K., Yang, L., van Rooijen, N., Ohnishi, H., & Seki, E. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00365.2011 · Cited by 503 · see citing works

Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9

Garcia-Martinez, I., Santoro, N., Chen, Y., Hoque, R., Ouyang, X., Caprio, S., Shlomchik, M. J., Coffman, R. L., Candia, A., & Mehal, W. Z. (2016) · Journal of Clinical Investigation · doi:10.1172/jci83885 · Cited by 498 · see citing works

Kupffer Cell Engulfment of Apoptotic Bodies Stimulates Death Ligand and Cytokine Expression

Canbay, A. E., Feldstein, A. E., Higuchi, H., Werneburg, N., Grambihler, A., Bronk, S. F., & Gores, G. J. (2003) · Hepatology · doi:10.1053/jhep.2003.50472 · Cited by 462 · see citing works

Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition

Charlton, M., Krishnan, A., Viker, K., Sanderson, S. O., Cazanave, S. C., McConico, A. L., Masuoko, H., & Gores, G. J. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00145.2011 · Cited by 444 · see citing works

p62, upregulated during preneoplasia, induces hepatocellular carcinogenesis by maintaining survival of stressed HCC-initiating cells

Umemura, A., He, F., Taniguchi, K., Nakagawa, H., Yamachika, S., Font-Burgada, J., Zhong, Z., Subramaniam, S., Raghunandan, S., Duran, A., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.04.006 · Cited by 438 · see citing works

β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson’s disease

Mittal, S., Bjørnevik, K., Im, D. S., Flierl, A., Dong, X., Locascio, J. J., Abo, K. M., Long, E., Jin, M., Xu, B. Y., et al. (2017) · Science · doi:10.1126/science.aaf3934 · Cited by 417 · see citing works

Kuppfer Cells Trigger Nonalcoholic Steatohepatitis Development in Diet-induced Mouse Model through Tumor Necrosis Factor-α Production

Tosello-Trampont, A.-C., Landes, S. G., Nguyen, V., Novobrantseva, T. I., & Hahn, Y. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.417014 · Cited by 415 · see citing works

Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease

Rotman, Y., & Sanyal, A. J. (2016) · Gut · doi:10.1136/gutjnl-2016-312431 · Cited by 410 · see citing works

Qualitative differences in T‐cell activation by dendritic cell‐derived extracellular vesicle subtypes

Tkach, M., Kowal, J., Zucchetti, A. E., Enserink, L. N. F. L., Jouve, M. J., Lankar, D., Saitakis, M., Jaular, L. M., & Théry, C. (2017) · The EMBO Journal · doi:10.15252/embj.201696003 · Cited by 381 · see citing works

Nanoplasmonic quantification of tumour-derived extracellular vesicles in plasma microsamples for diagnosis and treatment monitoring

Liang, K., Liu, F., Fan, J., Sun, D., Liu, C., Lyon, C. J., Bernard, D. W., Li, Y., Yokoi, K., Katz, M. H. G., et al. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-016-0021 · Cited by 368 · see citing works

Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes

Ahmed, A., Wong, R. J., & Harrison, S. A. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.07.029 · Cited by 330 · see citing works

The pan‐caspase inhibitor Emricasan ( IDN ‐6556) decreases liver injury and fibrosis in a murine model of non‐alcoholic steatohepatitis

Barreyro, F. J., Holod, S., Finocchietto, P. V., Camino, A. M., Aquino, J. B., Avagnina, A., Carreras, M. C., Poderoso, J. J., & Gores, G. J. (2014) · Liver International · doi:10.1111/liv.12570 · Cited by 295 · see citing works

Hepatocyte Toll-like receptor 4 regulates obesity-induced inflammation and insulin resistance

Jia, L., Vianna, C. R., Fukuda, M., Berglund, E. D., Liu, C., Tao, C., Sun, K., Liu, T., Harper, M. J., Lee, C. E., et al. (2014) · Nature Communications · doi:10.1038/ncomms4878 · Cited by 294 · see citing works

Toll-Like Receptor 2 and Palmitic Acid Cooperatively Contribute to the Development of Nonalcoholic Steatohepatitis Through Inflammasome Activation in Mice

Miura, K., Yang, L., van Rooijen, N., Brenner, D. A., Ohnishi, H., & Seki, E. (2012) · Hepatology · doi:10.1002/hep.26081 · Cited by 282 · see citing works

Insulin-Like Growth Factor System in Cancer: Novel Targeted Therapies

Brahmkhatri, V. P., Prasanna, C., & Atreya, H. S. (2015) · BioMed Research International · doi:10.1155/2015/538019 · Cited by 281 · see citing works

Hepatocytes release ceramide-enriched pro-inflammatory extracellular vesicles in an IRE1α-dependent manner

Kakazu, E., Mauer, A. S., Yin, M., & Malhi, H. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m063412 · Cited by 280 · see citing works

Circulating Extracellular Vesicles with Specific Proteome and Liver MicroRNAs Are Potential Biomarkers for Liver Injury in Experimental Fatty Liver Disease

Povero, D., Eguchi, A., Li, H., Johnson, C. D., Papouchado, B. G., Wree, A., Messer, K. S., & Feldstein, A. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113651 · Cited by 272 · see citing works

Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis

Hirsova, P., Ibrabim, S. H., Gores, G. J., & Malhi, H. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r066357 · Cited by 270 · see citing works

Nuclear factor high-mobility group box1 mediating the activation of toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice

Li, L., Chen, L., Hu, L., Liu, Y., Sun, H., Tang, J. P., Hou, Y.-J., Chang, Y., Tu, Q., Feng, G., et al. (2011) · Hepatology · doi:10.1002/hep.24552 · Cited by 236 · see citing works

Mixed lineage kinase 3 mediates release of C‐X‐C motif ligand 10–bearing chemotactic extracellular vesicles from lipotoxic hepatocytes

Ibrahim, S. H., Hirsova, P., Tomita, K., Bronk, S. F., Werneburg, N. W., Harrison, S. A., Goodfellow, V. S., Malhi, H., & Gores, G. J. (2016) · Hepatology · doi:10.1002/hep.28252 · Cited by 232 · see citing works

RAL-1 controls multivesicular body biogenesis and exosome secretion

Hyenne, V., Apaydin, A., Rodriguez, D., Spiegelhalter, C., Hoff-Yoessle, S., Diem, M., Tak, S., Lefèbvre, O., Schwab, Y., Goetz, J. G., et al. (2015) · The Journal of Cell Biology · doi:10.1083/jcb.201504136 · Cited by 230 · see citing works

Extracellular Vesicles in Liver Pathobiology: Small Particles With Big Impact

Hirsova, P., Ibrahim, S. H., Verma, V. K., Morton, L. A., Shah, V. H., LaRusso, N. F., Gores, G. J., & Malhi, H. (2016) · Hepatology · doi:10.1002/hep.28814 · Cited by 229 · see citing works

Fas/CD95-Induced Chemokines Can Serve as “Find-Me” Signals for Apoptotic Cells

Cullen, S. P., Henry, C. M., Kearney, C. J., Logue, S. E., Feoktistova, M., Tynan, G. A., Lavelle, E. C., Leverkus, M., & Martin, S. J. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.025 · Cited by 222 · see citing works

Lipid-Induced Hepatocyte-Derived Extracellular Vesicles Regulate Hepatic Stellate Cells via MicroRNA Targeting Peroxisome Proliferator-Activated Receptor-γ

Povero, D., Panera, N., Eguchi, A., Johnson, C. D., Papouchado, B. G., de Araujo Horcel, L., Pinatel, E. M., Alisi, A., Nobili, V., & Feldstein, A. E. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.07.007 · Cited by 221 · see citing works

CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis

Zhang, X., Shen, J., Man, K., Chu, E. S., Yau, T. O., Sung, J. C. Y., Go, M. Y. Y., Deng, J., Lu, L., Wong, V. W., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.006 · Cited by 219 · see citing works

Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease

Guy, C. D., Suzuki, A., Zdanowicz, M., Abdelmalek, M. F., Burchette, J. L., Ünalp, A., & Diehl, A. M. (2011) · Hepatology · doi:10.1002/hep.25559 · Cited by 217 · see citing works

Therapy of Experimental NASH and Fibrosis with Galectin Inhibitors

Traber, P. G., & Zomer, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083481 · Cited by 209 · see citing works

Lipid-Induced Toxicity Stimulates Hepatocytes to Release Angiogenic Microparticles That Require Vanin-1 for Uptake by Endothelial Cells

Povero, D., Eguchi, A., Niesman, I. R., Andronikou, N., du Jeu, X. D. M., Mulya, A., Berk, M. P., Lazić, M., Thapaliya, S., Parola, M., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004512 · Cited by 207 · see citing works

Circulating Microparticles as Disease-Specific Biomarkers of Severity of Inflammation in Patients With Hepatitis C or Nonalcoholic Steatohepatitis

Kornek, M., Lynch, M., Mehta, S. H., Lai, M., Exley, M. A., Afdhal, N. H., & Schuppan, D. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.031 · Cited by 203 · see citing works

Increased production of sonic hedgehog by ballooned hepatocytes

Rangwala, F., Guy, C. D., Lu, J., Suzuki, A., Burchette, J. L., Abdelmalek, M. F., Chen, W., & Diehl, A. M. (2011) · The Journal of Pathology · doi:10.1002/path.2888 · Cited by 201 · see citing works

Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: a phase II randomised study

Mayer, L., Sandborn, W. J., Stepanov, Y. M., Geboes, K. J., Hardi, R., Yellin, M. J., Tao, X., Xu, L. A., Salter–Cid, L., Gujrathi, S., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-303424 · Cited by 188 · see citing works

Death Receptor-Mediated Cell Death and Proinflammatory Signaling in Nonalcoholic Steatohepatitis

Hirsova, P., & Gores, G. (2014) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2014.11.005 · Cited by 184 · see citing works

Pharmacological correction of obesity-induced autophagy arrest using calcium channel blockers

Park, H., Park, H., Semple, I. A., Jang, I., Ro, S., Kim, M., Cazares, V. A., Stuenkel, E. L., Kim, J., Kim, J. S., et al. (2014) · Nature Communications · doi:10.1038/ncomms5834 · Cited by 182 · see citing works

Randomised clinical study: GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosis

Harrison, S. A., Marri, S., Chalasani, N., Kohli, R., Aronstein, W. S., Thompson, G. A., Irish, W. D., Miles, M. V., Xanthakos, S. A., Lawitz, E., et al. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13816 · Cited by 176 · see citing works

Immature myeloid cells induced by a high-fat diet contribute to liver inflammation #

Deng, Z., Liu, Y., Liu, C., Xiang, X., Wang, J., Cheng, Z., Shah, S. V., Zhang, S., Zhang, L., Zhuang, X., et al. (2009) · Hepatology · doi:10.1002/hep.23148 · Cited by 149 · see citing works

Hedgehog signalling in liver pathophysiology

Machado, M. V., & Diehl, A. M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.10.017 · Cited by 149 · see citing works

Mallory body—A disease-associated type of sequestosome

Stumptner, C., Fuchsbichler, A., Heid, H., Zatloukal, K., & Denk, H. (2002) · Hepatology · doi:10.1053/jhep.2002.32674 · Cited by 133 · see citing works

CXCL10-Mediates Macrophage, but not Other Innate Immune Cells-Associated Inflammation in Murine Nonalcoholic Steatohepatitis

Tomita, K., Freeman, B. L., Bronk, S. F., LeBrasseur, N. K., White, T. A., Hirsova, P., & Ibrahim, S. H. (2016) · Scientific Reports · doi:10.1038/srep28786 · Cited by 128 · see citing works

Apoptosis is associated with CD36/fatty acid translocase upregulation in non-alcoholic steatohepatitis

Bechmann, L. P., Gieseler, R. K. H., Sowa, J., Kahraman, A., ERHARD, J., Wedemeyer, I., Emons, B., Jochum, C., Feldkamp, T., Gerken, G., et al. (2009) · Liver International · doi:10.1111/j.1478-3231.2010.02248.x · Cited by 120 · see citing works

Neutrophil-derived myeloperoxidase aggravates non-alcoholic steatohepatitis in low-density lipoprotein receptor-deficient mice

Rensen, S. S., Bieghs, V., Xanthoulea, S., Arfianti, E., Bakker, J. A., Shiri-Sverdlov, R., Hofker, M. H., Greve, J. W., & Buurman, W. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052411 · Cited by 116 · see citing works

Major Histocompatibility Complex Class I–Related Chains A and B (Mic A/B): A Novel Role in Nonalcoholic Steatohepatitis

Kahraman, A., Schlattjan, M., Kocabayoglu, P., Yildiz-Meziletoglu, S., Schlensak, M., Fingas, C. D., Wedemeyer, I., Marquitan, G., Gieseler, R. K. H., Baba, H. A., et al. (2009) · Hepatology · doi:10.1002/hep.23253 · Cited by 116 · see citing works

Inhibition of sphingosine 1-phosphate signaling ameliorates murine nonalcoholic steatohepatitis

Mauer, A. S., Hirsova, P., Maiers, J. L., Shah, V. H., & Malhi, H. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00222.2016 · Cited by 96 · see citing works

CD11c+ resident macrophages drive hepatocyte death-triggered liver fibrosis in a murine model of nonalcoholic steatohepatitis

Itoh, M., Suganami, T., Kato, H., Kanai, S., Shirakawa, I., Sakai, T., Goto, T., Asakawa, M., Hidaka, I., Sakugawa, H., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.92902 · Cited by 94 · see citing works

Immunoaffinity based methods are superior to kits for purification of prostate derived extracellular vesicles from plasma samples

Brett, S. I., Lucien, F., Guo, C. C., Williams, K. C., Kim, Y., Durfee, P. N., Brinker, C. J., Chin, J., Yang, J., & Leong, H. S. (2017) · The Prostate · doi:10.1002/pros.23393 · Cited by 88 · see citing works

Vismodegib Suppresses TRAIL-mediated Liver Injury in a Mouse Model of Nonalcoholic Steatohepatitis

Hirsova, P., Ibrahim, S. H., Bronk, S. F., Yagita∥, H., & Gores, G. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070599 · Cited by 86 · see citing works

Inhibition of hedgehog signaling ameliorates hepatic inflammation in mice with nonalcoholic fatty liver disease

Kwon, H., Song, K., Han, C. L., Chen, W., Wang, Y., Dash, S., Lim, K., & Wu, T. (2015) · Hepatology · doi:10.1002/hep.28289 · Cited by 86 · see citing works

Association of Nonalcoholic Fatty Liver Disease with Subclinical Cardiovascular Changes: A Systematic Review and Meta-Analysis

Bonci, E., Chiesa, C., Versacci, P., Anania, C., Silvestri, L. M., & Pacifico, L. (2015) · BioMed Research International · doi:10.1155/2015/213737 · Cited by 81 · see citing works

Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis

Greuter, T., Malhi, H., Gores, G. J., & Shah, V. H. (2017) · JCI Insight · doi:10.1172/jci.insight.95354 · Cited by 67 · see citing works

A hedgehog survival pathway in ‘undead’ lipotoxic hepatocytes

Kakisaka, K., Cazanave, S. C., Werneburg, N. W., Razumilava, N., Mertens, J. C., Bronk, S. F., & Gores, G. J. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.05.011 · Cited by 65 · see citing works

Targeting Kupffer cells in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why and how?

Lanthier, N. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i19.2184 · Cited by 60 · see citing works

Mixed Lineage Kinase 3 Mediates the Induction of CXCL10 by a STAT1‐Dependent Mechanism During Hepatocyte Lipotoxicity

Tomita, K., Kabashima, A., Freeman, B. L., Bronk, S. F., Hirsova, P., & Ibrahim, S. H. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25973 · Cited by 53 · see citing works

TRAIL deletion prevents liver inflammation but not adipose tissue inflammation during murine diet‐induced obesity

Hirsova, P., Weng, P., Salim, W., Bronk, S. F., Griffith, T. S., Ibrahim, S. H., & Gores, G. J. (2017) · Hepatology Communications · doi:10.1002/hep4.1069 · Cited by 41 · see citing works

Ballooned hepatocytes, undead cells, sonic hedgehog, and Vitamin E: Therapeutic implications for nonalcoholic steatohepatitis

Hirsova, P., & Gores, G. J. (2014) · Hepatology · doi:10.1002/hep.27279 · Cited by 40 · see citing works

Mixed-lineage kinase 3 pharmacological inhibition attenuates murine nonalcoholic steatohepatitis

Tomita, K., Kohli, R., MacLaurin, B. L., Hirsova, P., Guo, Q., Sanchez, L. H. G., Gelbard, H. A., Blaxall, B. C., & Ibrahim, S. H. (2017) · JCI Insight · doi:10.1172/jci.insight.94488 · Cited by 34 · see citing works

LP37 : A placebo-controlled, multicenter, double-blind, randomised trial of emricasan in subjects with non-alcoholic fatty liver disease (NAFLD) and raised transaminases

Shiffman, M. L., Freilich, B. L., Vuppalanchi, R., Watt, K. D. S., Burgess, G., Morris, M., Sheedy, B., & Schiff, E. R. (2015) · Journal of Hepatology · doi:10.1016/s0168-8278(15)30191-4 · Cited by 31 · see citing works

Cellular Injury in Liver Diseases

Yin, X., & Ding, W. (2017) · Springer eBooks · doi:10.1007/978-3-319-53774-0 · Cited by 15 · see citing works

Is there a role for adaptive immunity in nonalcoholic steatohepatitis?

Sutti, S., Jindal, A., Bruzzì, S., Locatelli, I., Bozzola, C., & Albano, E. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i13.1725 · Cited by 14 · see citing works

Hepatocyte Lethal and Nonlethal Lipotoxic Injury

Hirsova, P., Ibrahim, S. H., Malhi, H., & Gores, G. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-53774-0_5 · Cited by 3 · see citing works

Mechanisms and disease consequences of nonalcoholic fatty liver disease

Loomba, R., Friedman, S. L., & Shulman, G. I. (2021) · Cell · doi:10.1016/j.cell.2021.04.015 · Cited by 2,002 · see citing works

Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases

Li, H., Zuo, J., & Tang, W. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01048 · Cited by 580 · see citing works

Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?

Rada, P., González‐Rodríguez, Á., García‐Monzón, C., & Valverde, Á. M. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03003-w · Cited by 522 · see citing works

Pathogenesis of Nonalcoholic Steatohepatitis: An Overview

Parthasarathy, G., Revelo, X. S., & Malhi, H. (2020) · Hepatology Communications · doi:10.1002/hep4.1479 · Cited by 420 · see citing works

Role of liver sinusoidal endothelial cells in liver diseases

Gracia‐Sancho, J., Caparrós, E., Fernández‐Iglesias, A., & Francés, R. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00411-3 · Cited by 425 · see citing works

Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH)

Xu, X., Poulsen, K. L., Wu, L., Liu, S., Miyata, T., Song, Q., Wei, Q., Zhao, C., Lin, C., & Yang, J. B. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01119-3 · Cited by 370 · see citing works

Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis

Kumar, S., Duan, Q., Wu, R., Harris, E. N., & Su, Q. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113869 · Cited by 355 · see citing works

Resolution of NASH and hepatic fibrosis by the GLP-1R and GCGR dual-agonist cotadutide via modulating mitochondrial function and lipogenesis

Boland, M. L., Laker, R. C., Mather, K., Nawrocki, A., Oldham, S., Boland, B. B., Lewis, H., Conway, J., Naylor, J., Guionaud, S., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0209-6 · Cited by 270 · see citing works

Hepatocyte-derived extracellular vesicles promote endothelial inflammation and atherogenesis via microRNA-1

Jiang, F., Chen, Q., Wang, W., Ling, Y., Yan, Y., & Xia, P. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.09.014 · Cited by 267 · see citing works

Lytic cell death in metabolic liver disease

Gautheron, J., Gores, G. J., & Rodrigues, C. M. P. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.04.001 · Cited by 225 · see citing works

Immunological mechanisms and therapeutic targets of fatty liver diseases

Wang, H., Mehal, W. Z., Nagy, L. E., & Rotman, Y. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00579-3 · Cited by 222 · see citing works

Liver fibrosis in NAFLD/NASH: from pathophysiology towards diagnostic and therapeutic strategies

Parola, M., & Pinzani, M. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101231 · Cited by 226 · see citing works

The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease

Díaz, L. A., Arab, J. P., Louvet, A., Bataller, R., & Arrese, M. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00822-y · Cited by 207 · see citing works

Chronic Inflammation in Non-Alcoholic Steatohepatitis: Molecular Mechanisms and Therapeutic Strategies

Luci, C., Bourinet, M., Leclère, P. S., Anty, R., & Gual, P. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.597648 · Cited by 195 · see citing works

Interleukin‐22 Ameliorates Neutrophil‐Driven Nonalcoholic Steatohepatitis Through Multiple Targets

Hwang, S., He, Y., Xiang, X., Seo, W., Kim, S., Ma, J., Ren, T., Park, S. H., Zhou, Z., Feng, D., et al. (2019) · Hepatology · doi:10.1002/hep.31031 · Cited by 180 · see citing works

Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review

Cariou, B., Byrne, C. D., Loomba, R. S., & Sanyal, A. J. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14322 · Cited by 174 · see citing works

MicroRNA‐223 Ameliorates Nonalcoholic Steatohepatitis and Cancer by Targeting Multiple Inflammatory and Oncogenic Genes in Hepatocytes

He, Y., Hwang, S., Cai, Y., Kim, S., Xu, M., Yang, D., Guillot, A., Feng, D., Seo, W., Hou, X., et al. (2019) · Hepatology · doi:10.1002/hep.30645 · Cited by 150 · see citing works

Lipid-induced endothelial vascular cell adhesion molecule 1 promotes nonalcoholic steatohepatitis pathogenesis

Furuta, K., Guo, Q., Pavelko, K. D., Lee, J.-H., Robertson, K. D., Nakao, Y., Melek, J., Shah, V. H., Hirsova, P., & Ibrahim, S. H. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143690 · Cited by 136 · see citing works

Breakthroughs in therapies for NASH and remaining challenges

Ratziu, V., Francque, S., & Sanyal, A. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.04.002 · Cited by 132 · see citing works

Hepatocytes: A key role in liver inflammation

Gong, J., Tu, W., Liu, J., & Tian, D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1083780 · Cited by 128 · see citing works

Understanding the cellular interactome of non-alcoholic fatty liver disease

Wallace, S. J., Tacke, F., Schwabe, R. F., & Henderson, N. C. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100524 · Cited by 116 · see citing works

Di-2-ethylhexyl phthalate (DEHP) induced lipid metabolism disorder in liver via activating the LXR/SREBP-1c/PPARα/γ and NF-κB signaling pathway

Huang, Y.-Q., Tang, Y.-X., Qiu, B.-H., Talukder, M., Li, X., & Li, J. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.113119 · Cited by 114 · see citing works

Disorganization and degeneration of liver sympathetic innervations in nonalcoholic fatty liver disease revealed by 3D imaging

Adori, C., Daraio, T., Kuiper, R., Barde, S., Horvathova, L., Yoshitake, T., Ihnatko, R., Valladolid-Acebes, I., Vercruysse, P., Wellendorf, A. M., et al. (2021) · Science Advances · doi:10.1126/sciadv.abg5733 · Cited by 105 · see citing works

Yes-associated protein in kupffer cells enhances the production of proinflammatory cytokines and promotes the development of nonalcoholic steatohepatitis

Song, K., Kwon, H., Han, C., Chen, W., Zhang, J., Ma, W., Dash, S., Gandhi, C. R., & Wu, T. (2020) · Hepatology · doi:10.1002/hep.30990 · Cited by 110 · see citing works

Paraoxonase-1 as a Regulator of Glucose and Lipid Homeostasis: Impact on the Onset and Progression of Metabolic Disorders

Meneses, M. J., Silvestre, R. D., Sousa‐Lima, I., & Macedo, M. P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20164049 · Cited by 114 · see citing works

Nonalcoholic steatohepatitis (NASH) – current treatment recommendations and future developments

Roeb, E., & Geier, A. (2019) · Zeitschrift für Gastroenterologie · doi:10.1055/a-0784-8827 · Cited by 106 · see citing works

Hepatic Stellate Cell Activation and Inactivation in NASH-Fibrosis—Roles as Putative Treatment Targets?

Zisser, A., Ipsen, D. H., & Tveden‐Nyborg, P. (2021) · Biomedicines · doi:10.3390/biomedicines9040365 · Cited by 111 · see citing works

Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease

Khambu, B., Yan, S., Huda, N., Liu, G., & Yin, X. (2018) · Liver Research · doi:10.1016/j.livres.2018.09.004 · Cited by 105 · see citing works

Steatosis in Liver Transplantation: Current Limitations and Future Strategies

Linares, I., Hamar, M., Selzner, N., & Selzner, M. (2018) · Transplantation · doi:10.1097/tp.0000000000002466 · Cited by 104 · see citing works

Tripartite motif 16 ameliorates nonalcoholic steatohepatitis by promoting the degradation of phospho-TAK1

Wang, L., Zhang, X., Lin, Z., Yang, P., Xu, H., Duan, J., Ruan, B., Song, P., Liu, J., Yue, Z., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.05.019 · Cited by 104 · see citing works

Human Nonalcoholic Steatohepatitis on a Chip

Freag, M. S., Namgung, B., Reyna Fernandez, M. E., Gherardi, E., Sengupta, S., & Jang, H. L. (2021) · Hepatology Communications · doi:10.1002/hep4.1647 · Cited by 102 · see citing works

Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease

Katsarou, A., Moustakas, I. I., Pyrina, I., Lembessis, P., Koutsilieris, M., & Chatzigeorgiou, A. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i17.1993 · Cited by 102 · see citing works

Hepatocyte-Derived Lipotoxic Extracellular Vesicle Sphingosine 1-Phosphate Induces Macrophage Chemotaxis

Liao, C., Song, M. J., Gao, Y., Mauer, A. S., Revzin, A., & Malhi, H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02980 · Cited by 99 · see citing works

Nuclear receptors linking metabolism, inflammation, and fibrosis in nonalcoholic fatty liver disease

Puengel, T., Liu, H., Guillot, A., Heymann, F., Tacke, F., & Peiseler, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052668 · Cited by 95 · see citing works

Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome

Lim, S. K., Taskinen, M., & Borén, J. (2018) · Obesity Reviews · doi:10.1111/obr.12820 · Cited by 95 · see citing works

ANGPTL8 accelerates liver fibrosis mediated by HFD-induced inflammatory activity via LILRB2/ERK signaling pathways

Zhang, Z., Yuan, Y., Hu, L., Tang, J., Meng, Z., Dai, L., Gao, Y., Ma, S., Wang, X., Yuan, Y., et al. (2022) · Journal of Advanced Research · doi:10.1016/j.jare.2022.08.006 · Cited by 96 · see citing works

Role of extracellular vesicles in liver diseases and their therapeutic potential

Kostallari, E., Valainathan, S. R., Biquard, L., Shah, V. H., & Rautou, P. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.026 · Cited by 92 · see citing works

Mitochondrial oxidative injury: a key player in nonalcoholic fatty liver disease

Dornas, W. C., & Schuppan, D. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00121.2020 · Cited by 90 · see citing works

Oncostatin M and its role in fibrosis

Stawski, L., & Trojanowska, M. (2019) · Connective Tissue Research · doi:10.1080/03008207.2018.1500558 · Cited by 86 · see citing works

Targeting cell-intrinsic metabolism for antifibrotic therapy

Gilgenkrantz, H., Mallat, A., Moreau, R., & Lotersztajn, S. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.02.012 · Cited by 76 · see citing works

AASLD Practice Statement on the evaluation and management of metabolic dysfunction–associated steatotic liver disease in children

Xanthakos, S. A., Ibrahim, S. H., Adams, K. H., Kohli, R., Sathya, P., Sundaram, S. S., Vos, M. B., Dhawan, A., Caprio, S., Behling, C. A., et al. (2025) · Hepatology · doi:10.1097/hep.0000000000001368 · Cited by 86 · see citing works

Hepatocyte TNF Receptor–Associated Factor 6 Aggravates Hepatic Inflammation and Fibrosis by Promoting Lysine 6–Linked Polyubiquitination of Apoptosis Signal‐Regulating Kinase 1

Wang, Y., Wen, H., Fu, J., Cai, L., Li, P., Zhao, C., Dong, Z., Ma, J., Wang, X., Tian, H., et al. (2019) · Hepatology · doi:10.1002/hep.30822 · Cited by 79 · see citing works

Pathogenesis of Nonalcoholic Steatohepatitis and Hormone-Based Therapeutic Approaches

Kim, K. H., & Lee, M. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00485 · Cited by 77 · see citing works

Role of High-Mobility Group Box-1 in Liver Pathogenesis

Khambu, B., Yan, S., Huda, N., & Yin, X. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215314 · Cited by 76 · see citing works

Protective and Detrimental Roles of p38α MAPK in Different Stages of Nonalcoholic Fatty Liver Disease

Hwang, S., Wang, X.-L., Rodrigues, R., Ma, J., He, Y., Seo, W., Park, S., Kim, S.-J., Feng, D., & Gao, B. (2020) · Hepatology · doi:10.1002/hep.31390 · Cited by 67 · see citing works

Metabolic Reprogramming of Liver Fibrosis

Delgado, M. E., Cárdenas, B., Farran, N., & Fernández, M. (2021) · Cells · doi:10.3390/cells10123604 · Cited by 73 · see citing works

Regulatory Non-coding RNAs Network in Non-alcoholic Fatty Liver Disease

Sulaiman, S. A., Muhsin, N. I. A., & Jamal, R. A. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00279 · Cited by 72 · see citing works

Selective Isolation of Liver-Derived Extracellular Vesicles Redefines Performance of miRNA Biomarkers for Non-Alcoholic Fatty Liver Disease

Newman, L. A., Useckaite, Z., Johnson, J. G., Sorich, M. J., Hopkins, A. M., & Rowland, A. (2022) · Biomedicines · doi:10.3390/biomedicines10010195 · Cited by 72 · see citing works

Non-alcoholic fatty liver disease: the pathologist’s perspective

Leow, W. Q., Chan, A. W. H., Mendoza, P. G. L., Lo, R. C., Yap, K., & Kim, H. (2022) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0329 · Cited by 70 · see citing works

Spermidine ameliorates non-alcoholic fatty liver disease through regulating lipid metabolism via AMPK

Gao, M., Zhao, W. M., Li, C., Xie, X., Li, M., Bi, Y., Fang, F., Du, Y., & Liu, X. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.09.078 · Cited by 69 · see citing works

Chemical hypoxia induces pro-inflammatory signals in fat-laden hepatocytes and contributes to cellular crosstalk with Kupffer cells through extracellular vesicles

Hernández, A., Geng, Y., Sepúlveda, R., Solı́s, N., Torres, J., Arab, J. P., Francisco Barrera, M., Cabrera, D., Moshage, H. J., & Arrese, M. A. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165753 · Cited by 64 · see citing works

Upregulation of miR-96-5p by bone marrow mesenchymal stem cells and their exosomes alleviate non-alcoholic steatohepatitis: Emphasis on caspase-2 signaling inhibition

El-Derany, M. O., & AbdelHamid, S. G. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114624 · Cited by 64 · see citing works

Hepatocyte-derived exosomal miR-27a activates hepatic stellate cells through the inhibition of PINK1-mediated mitophagy in MAFLD

Luo, X., Xu, Z., Wu, J.-C., Luo, S., & Xu, M. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.10.022 · Cited by 64 · see citing works

Age-related liver endothelial zonation triggers steatohepatitis by inactivating pericentral endothelium-derived C-kit

Duan, J., Liu, J., Ruan, B., Ding, J. H., Fang, Z.-Q., Xu, H., Song, P., Chen, X., Li, Z., Du, W., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00348-z · Cited by 63 · see citing works

Hepatocyte Injury and Hepatic Stem Cell Niche in the Progression of Non-Alcoholic Steatohepatitis

Overi, D., Carpino, G., Franchitto, A., Onori, P., & Gaudio, E. (2020) · Cells · doi:10.3390/cells9030590 · Cited by 61 · see citing works

Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD: A promising drug Potentilla discolor Bunge

Ji, L., Li, Q., He, Y., Zhang, X., Zhou, Z., Gao, Y., Fang, M., Yu, Z., Rodrigues, R. M., Gao, Y., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.05.001 · Cited by 59 · see citing works

Exercise suppresses NLRP3 inflammasome activation in mice with diet-induced NASH: a plausible role of adropin

Yang, W., Liu, L., Wei, Y., Fang, C., Liu, S., Zhou, F., Li, Y., Zhao, G., Guo, Z., Luo, Y., et al. (2020) · Laboratory Investigation · doi:10.1038/s41374-020-00508-y · Cited by 58 · see citing works

Molecular magnetic resonance imaging accurately measures the antifibrotic effect of EDP‐305, a novel farnesoid X receptor agonist

Erstad, D. J., Farrar, C. T., Ghoshal, S., Masia, R., Ferreira, D. S., Chen, Y. I., Choi, J., Wei, L., Waghorn, P. A., Rotile, N. J., et al. (2018) · Hepatology Communications · doi:10.1002/hep4.1193 · Cited by 58 · see citing works

ASGR1 promotes liver injury in sepsis by modulating monocyte-to-macrophage differentiation via NF-κB/ATF5 pathway

Shi, R., Wang, J., Zhang, Z., Leng, Y., & Chen, A. F. (2023) · Life Sciences · doi:10.1016/j.lfs.2022.121339 · Cited by 57 · see citing works

Biological mechanisms and related natural modulators of liver X receptor in nonalcoholic fatty liver disease

Ni, M., Zhang, B., Zhao, J., Feng, Q., Peng, J., Hu, Y., & Zhao, Y. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108778 · Cited by 56 · see citing works

Long-term Metabolic Morbidity and Steatohepatosis Following Standard Pancreatic Resections and Parenchyma-sparing, Local Extirpations for Benign Tumor

Beger, H. G., Mayer, B., Vasilescu, C., & Poch, B. (2021) · Annals of Surgery · doi:10.1097/sla.0000000000004757 · Cited by 55 · see citing works

Saturated fatty acid-enriched small extracellular vesicles mediate a crosstalk inducing liver inflammation and hepatocyte insulin resistance

García‐Martinez, I., Alén, R., Pereira, L., Povo‐Retana, A., Astudillo, A. M., Hitos, A. B., Gómez‐Hurtado, I., López‐Collazo, E., Boscá, L., Francés, R., et al. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100756 · Cited by 56 · see citing works

Protection against nonalcoholic steatohepatitis through targeting IL-18 and IL-1alpha by luteolin

Abu‐Elsaad, N., & El-Karef, A. (2019) · Pharmacological Reports · doi:10.1016/j.pharep.2019.03.009 · Cited by 54 · see citing works

Future trends in the treatment of non-alcoholic steatohepatitis

Fiorucci, S., Biagioli, M., & Distrutti, E. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.07.014 · Cited by 53 · see citing works

Activation of Liver mTORC1 Protects Against NASH via Dual Regulation of VLDL-TAG Secretion and De Novo Lipogenesis

Uehara, K., Sostre‐Colón, J., Gavin, M. J., Santoleri, D., Leonard, K., Jacobs, R. L., & Titchenell, P. M. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.02.015 · Cited by 51 · see citing works

A Comprehensive Study of High Cholesterol Diet-Induced Larval Zebrafish Model: A Short-Time In Vivo Screening Method for Non-Alcoholic Fatty Liver Disease Drugs

Ma, J., Yin, H., Li, M., Deng, Y., Ahmad, O., Qin, G., He, Q., Li, J., Gao, K., Zhu, J., et al. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.30013 · Cited by 49 · see citing works

Pericytes in the Liver

Kostallari, E., & Shah, V. H. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-11093-2_9 · Cited by 49 · see citing works

Neutrophil extracellular traps enriched with IL-1β and IL-17A participate in the hepatic inflammatory process of patients with non-alcoholic steatohepatitis

Arelaki, S., Κoletsa, T., Sinakos, E., Papadopoulos, V. P., Arvanitakis, K., Skendros, P., Akriviadis, E. A., Ritis, K., Germanidis, G. S., & Hytiroglou, P. (2022) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-022-03330-7 · Cited by 50 · see citing works

Emerging Roles of Liver Sinusoidal Endothelial Cells in Nonalcoholic Steatohepatitis

Furuta, K., Guo, Q.-Q., Hirsova, P., & Ibrahim, S. (2020) · Biology · doi:10.3390/biology9110395 · Cited by 45 · see citing works

Immunological distinctions between nonalcoholic steatohepatitis and hepatocellular carcinoma

Koo, S.-Y., Park, E.-J., & Lee, C.-W. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0480-3 · Cited by 47 · see citing works

Vicious Cycle‐Breaking Lipid Nanoparticles Remodeling Multicellular Crosstalk to Reverse Liver Fibrosis

Zhang, L., Deng, W., Huang, Q., Zhang, J., Wang, Y., Zhou, T., Xing, L., & Jiang, H. (2024) · Advanced Materials · doi:10.1002/adma.202311474 · Cited by 47 · see citing works

Novel Drivers of the Inflammatory Response in Liver Injury and Fibrosis

Wree, A., Holtmann, T. M., Inzaugarat, M. E., & Feldstein, A. E. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-1685515 · Cited by 47 · see citing works

Xenobiotic-Induced Aggravation of Metabolic-Associated Fatty Liver Disease

Massart, J., Begriche, K., Corlu, A., & Fromenty, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031062 · Cited by 46 · see citing works

From NAFLD to NASH: Understanding the spectrum of non-alcoholic liver diseases and their consequences

Samy, A. M., Kandeil, M. A., Sabry, D., Abdel-Ghany, A. A., & Mahmoud, M. O. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30387 · Cited by 50 · see citing works

Immune-metabolic interactions in homeostasis and the progression to NASH.

Hoogerland, J., Staels, B., & Dombrowicz, D. (2022) · Trends in endocrinology and metabolism · doi:10.1016/j.tem.2022.07.001 · Cited by 41 · see citing works

Pro- and anti-inflammatory cytokines are the game-changers in childhood obesity-associated metabolic disorders (diabetes and non-alcoholic fatty liver diseases)

Ullah, A., Singla, R. K., Batool, Z., Cao, D., & Shen, B. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09884-y · Cited by 45 · see citing works

Inflammation and Ectopic Fat Deposition in the Aging Murine Liver Is Influenced by CCR2

Stahl, E. C., Delgado, E. R., Alencastro, F., LoPresti, S. T., Wilkinson, P. D., Roy, N., Haschak, M. J., Skillen, C. D., Monga, S. P., Duncan, A. W., et al. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.10.016 · Cited by 44 · see citing works

Controversies and Opportunities in the Use of Inflammatory Markers for Diagnosis or Risk Prediction in Fatty Liver Disease

Lambrecht, J., & Tacke, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.634409 · Cited by 44 · see citing works

Differential role of MLKL in alcohol-associated and non–alcohol-associated fatty liver diseases in mice and humans

Miyata, T., Wu, X.-Q., Fan, X., Huang, E., Sanz-García, C., Cajigas-DuRoss, C., Roychowdhury, S., Bellar, A., McMullen, M., Dasarathy, J., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.140180 · Cited by 44 · see citing works

Hepatoprotective effect of dihydroxy piperlongumine in high cholesterol-induced non-alcoholic fatty liver disease zebrafish via antioxidant activity

Haridevamuthu, B., Boopathi, S., Priya, P. S., Muthuraman, S., Kumar, R. S., Manikandan, K., Almutairi, B. O., Almutairi, M. H., Arokiyaraj, S., Gopinath, P., et al. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175605 · Cited by 43 · see citing works

Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment

Zhu, B., Chan, S., Li, J., Li, K. S., Wu, H., Cui, K., & Chen, H. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.742382 · Cited by 46 · see citing works

Roles of Hepatic Innate and Innate-Like Lymphocytes in Nonalcoholic Steatohepatitis

Chen, Y., & Tian, Z. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01500 · Cited by 47 · see citing works

Programmed cell death and lipid metabolism of macrophages in NAFLD

Xiao, Z., Liu, M., Yang, F., Liu, G., Liu, J., Zhao, W., Ma, S., & Duan, Z. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1118449 · Cited by 41 · see citing works

Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

Feng, G., Li, X., Niu, C.-Y., Liu, M.-L., Yan, Q.-Q., Fan, L., Li, Y., Zhang, K., Gao, J., Qian, M., et al. (2020) · Gene · doi:10.1016/j.gene.2020.144549 · Cited by 41 · see citing works

Integrating the contributions of mitochondrial oxidative metabolism to lipotoxicity and inflammation in NAFLD pathogenesis

Hughey, C. C., Puchalska, P., & Crawford, P. A. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2022.159209 · Cited by 42 · see citing works

No evidence for a causal link between Helicobacter pylori infection and nonalcoholic fatty liver disease: A bidirectional Mendelian randomization study

Liu, Y., Xu, H., Zhao, Z., Dong, Y., Wang, X., & Niu, J. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1018322 · Cited by 40 · see citing works

Myeloid Nrf2 deficiency aggravates non-alcoholic steatohepatitis progression by regulating YAP-mediated NLRP3 inflammasome signaling

Wang, P., Ni, M., Tian, Y., Wang, H., Qiu, J., You, W., Song, W., Shi, Y., Zhou, J., Cheng, F., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102427 · Cited by 40 · see citing works

MetALD: Clinical aspects, pathophysiology and treatment

Gratacós‐Ginès, J., Ariño, S., Sancho‐Bru, P., Bataller, R. A., & Pose, E. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101250 · Cited by 42 · see citing works

Hepatic IRF2BP2 Mitigates Nonalcoholic Fatty Liver Disease by Directly Repressing the Transcription of ATF3

Fang, J., Ji, Y., Zhang, P., Cheng, L., Chen, Y., Chen, J., Su, Y., Cheng, X., Zhang, Y., Li, T., et al. (2019) · Hepatology · doi:10.1002/hep.30950 · Cited by 39 · see citing works

Role of Extracellular Vesicles in the Pathophysiology, Diagnosis and Tracking of Non-Alcoholic Fatty Liver Disease

Newman, L. A., Sorich, M. J., & Rowland, A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072032 · Cited by 39 · see citing works

Implantable Vascularized Liver Chip for Cross‐Validation of Disease Treatment with Animal Model

Lee, J. B., Park, J. S., Shin, Y. M., Lee, D. H., Yoon, J., Kim, D., Ko, U. H., Kim, Y., Bae, S. H., & Sung, H. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201900075 · Cited by 38 · see citing works

High-dose vitamin B1 therapy prevents the development of experimental fatty liver driven by overnutrition

Kalyesubula, M., Mopuri, R., Asiku, J., Rosov, A., Yosefi, S., Edery, N., Bocobza, S. E., Moallem, U., & Dvir, H. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.048355 · Cited by 37 · see citing works

Metabolic dysfunction and alcohol-associated liver disease (MetALD)

Gao, B., Arab, J. P., Liangpunsakul, S., Ding, W., Szabó, G., Mehal, W. Z., Wang, H., He, Y., Stärkel, P., Llorente, C., et al. (2025) · eGastroenterology · doi:10.1136/egastro-2025-100319 · Cited by 42 · see citing works

Role of Exosomes in Chronic Liver Disease Development and Their Potential Clinical Applications

Wang, C., Liu, J., Yan, Y., & Tan, Y. (2022) · Journal of Immunology Research · doi:10.1155/2022/1695802 · Cited by 36 · see citing works

Recent advances in liver‐on‐chips: Design, fabrication, and applications

Qiu, L., Kong, B., Kong, T., & Wang, H. (2023) · Smart Medicine · doi:10.1002/smmd.20220010 · Cited by 37 · see citing works

Comprehensive molecular mechanisms and clinical therapy in nonalcoholic steatohepatitis: An overview and current perspectives

Yan, M., Man, S., Ma, L., & Gao, W. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155264 · Cited by 35 · see citing works

The Interplay between Liver Sinusoidal Endothelial Cells, Platelets, and Neutrophil Extracellular Traps in the Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease

Minciună, I., Taru, M. G., Procopeț, B., & Ştefănescu, H. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13051406 · Cited by 34 · see citing works

SIRT1/NFκB pathway mediates anti-inflammatory and anti-apoptotic effects of rosmarinic acid on in a mouse model of nonalcoholic steatohepatitis (NASH)

Movahhed, T. K., Bassirian, M., Changizi, Z., & Moslehi, A. (2021) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2021.1905665 · Cited by 34 · see citing works

Early-life perfluorooctanoic acid exposure induces obesity in male offspring and the intervention role of chlorogenic acid

Shao, W., Xu, J., Xu, C. Y., Weng, Z., Liu, Q., Zhang, X., Liang, J., Li, W., Zhang, Y., Jiang, Z., et al. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2020.115974 · Cited by 33 · see citing works

Functional heterogeneity of CD4+ T cells in liver inflammation

Muscate, F., Woestemeier, A., & Gagliani, N. (2021) · Seminars in Immunopathology · doi:10.1007/s00281-021-00881-w · Cited by 32 · see citing works

Pathogenesis of Nonalcoholic Steatohepatitis: An Overview

Parthasarathy, G., Revelo, X. S., & Malhi, H. (2020) · Hepatology Communications · doi:10.1002/hep4.1479 · Cited by 420 · see citing works

Hepatocyte Lethal and Nonlethal Lipotoxic Injury

Hirsova, P., Ibrahim, S. H., Malhi, H., & Gores, G. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-53774-0_5 · Cited by 3 · see citing works

Current and Potential Therapies Targeting Inflammation in NASH

Albhaisi, S. A. M., & Noureddin, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.767314 · Cited by 44 · see citing works

Pathogenesis of nonalcoholic steatohepatitis

Liu, W., Baker, R. D., Bhatia, T., Zhu, L., & Baker, S. S. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2161-x · Cited by 225 · see citing works

Mechanisms of Liver Injury in Non-Alcoholic Steatohepatitis

Duwaerts, C. C., & Maher, J. J. (2014) · Current Hepatology Reports · doi:10.1007/s11901-014-0224-8 · Cited by 43 · see citing works